About Etna Biotech
Etna Biotech is a Healthcare company based in Catania (Italy) founded in 2001, and was acquired by Zydus Cadila in November 2008. Vaccines and immunotherapeutics for infectious and chronic diseases are developed. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Diversified.
Company details
Etna Biotech is a vaccine research center whose key competencies lie in researching and developing vaccines and immunotherapeutics for infectious diseases and other chronic illnesses. It currently has 13 vaccine candidates at different stages of development. Its lead product is the vaccine for the prevention of Typhoid infections which is currently in phase 3 trials. Etna Biotech was the start up of the former Swiss Serum and Vaccine Institute and later Berna Biotech. On 11th November 2008, Zydus Cadila acquired Etna Biotech for an undisclosed amount.
- Headquarters Catania, Italy
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website etnabiotech.it
- Social LinkedIn
- Acquired by Zydus Cadila (Nov 2008)
- Latest Funding Round$1.31M (USD), Grant
Feb 2018
- InvestorsZydus Cadila
& 1 more
- Acquired byZydus Cadila
(Nov 2008)
Funding Insights of Etna Biotech
- Total Rounds 1
- Last Round Grant — $1.31M
- First Round $1.31M
(Feb 2018)
- Investors Count 1
All 1 funding rounds of Etna Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2018 | $1.31M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Etna Biotech
Etna Biotech has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Zydus Cadila and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Pharmaceutical manufacturing, drug development, and healthcare services. | 1952 | zyduscadila.com | Ahmedabad, India |
Investor details for Etna Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Etna Biotech
3 dated milestones of Etna Biotech across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Etna Biotech is founded.
- Exit Acquired by Zydus Cadila.
- Funding First funding round of $1.3M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Etna Biotech
Etna Biotech was founded in 2001 and raised its 1st funding round 17 years after it was founded.
Etna Biotech is headquartered in Catania, Italy. It is registered at Catania, Sicily, Italy.
Etna Biotech is a vaccine research center whose key competencies lie in researching and developing vaccines and immunotherapeutics for infectious diseases and other chronic illnesses. It currently has 13 vaccine candidates at different stages of development. Its lead product is the vaccine for the prevention of Typhoid infections which is currently in phase 3 trials. Etna Biotech was the start up of the former Swiss Serum and Vaccine Institute and later Berna Biotech. On 11th November 2008, Zydus Cadila acquired Etna Biotech for an undisclosed amount.
Etna Biotech has 2 investors. Key investors include Zydus Cadila, and European Union.
Yes. Etna Biotech was acquired by Zydus Cadila in November 2008.